Document:

Exhibit 10.14

 

JERASH HOLDINGS (US), INC.

 

SUBSCRIPTION AGREEMENT 

 

This Subscription Agreement
(this “Subscription Agreement”) is dated _____________ ___, 2018, by and between the undersigned identified
on the Signature Page hereto (the “Investor”) and Jerash Holdings (US), Inc., a Delaware corporation (the “Company”).

 

WHEREAS, the Company has authorized the
sale and issuance of a minimum of 715,000 shares (the “Minimum Amount”) and up to a maximum of 1,430,000 (the
“Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), on a “best
efforts” basis at an initial public offering price of $7 per Share (the “Purchase Price”);

 

WHEREAS, the offering and sale of the
Shares (the “Offering”) are being made pursuant to an effective Registration Statement on Form S-1 (File No.
333-222596) (the “Registration Statement”) filed under the Securities Act of 1933, as amended (the “Securities
Act”), by the Company with the U.S. Securities and Exchange Commission (the “Commission”);

 

WHEREAS, the Company has entered into
an Underwriting Agreement, dated __________, 2018 (the “Underwriting Agreement”), with Network 1 Financial Securities,
Inc., a FINRA-registered broker/dealer, to act as the underwriter of the Shares in the Offering (the “Underwriter”);

 

WHEREAS, the Company, Underwriter and
Continental Stock Transfer & Trust Company have entered into an Escrow Agreement, dated _______, 2018 (the “Escrow
Agreement”), pursuant to which Continental Stock Transfer & Trust Company has agreed to serve as the escrow agent
in connection with the Offering (the “Escrow Agent”);

 

WHEREAS, the Investor desires to purchase
a certain amount of Shares from the Company.

 

NOW, THEREFORE,
in consideration of the foregoing and of the covenants contained herein, the sufficiency of which is hereby mutually accepted,
the parties hereby agree as follows:

 

		1.	Subscription.

 

		a.	Investor agrees to buy and the Company agrees to sell and
issue to Investor such number of Shares of Common Stock as set forth on the signature page hereto (the “Signature Page”),
for an aggregate purchase price equal to the product of (x) the aggregate number of Shares of Common Stock the Investor has agreed
to purchase and (y) the Purchase Price per Share.

 

		b.	The Common Shares are being offered by the Underwriter
on a “best efforts, minimum/maximum” basis. The completion of the purchase and sale of the Shares (the “Closing”)
shall take place at a place and time (the “Closing Date”) to be specified by the Company and Underwriter in
accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Upon satisfaction or waiver of all the conditions to closing set forth in the Underwriting Agreement and Registration Statement,
at the Closing, (i) the Investor shall pay the Purchase Price by check or by wire transfer of immediately available funds to the
Company’s escrow account per wire instructions as provided on the signature line below, and (ii) the Company shall cause
the Shares to be delivered to the Investor with the delivery of the Shares to be made through the facilities of The Depository
Trust Company’s (“DTC”) DWAC system in accordance with the instructions set forth on the signature page
attached hereto under the heading “DWAC Instructions” (or, if requested by the Investor on the signature page hereto,
through the physical delivery of certificates evidencing the Shares to the residential or business address indicated thereon).

  

    	 	1	 

     

    

 

		c.	The Underwriter and any participating broker dealers (the
“Members”) shall confirm, via the selected dealer agreement or master selected dealer agreement that it will
comply with Rule 15c2-4. As per Rule 15c2-4 and notice to members 84-7 (the “Rule”), all checks that are accompanied
by a subscription agreement will be promptly sent along with the subscription agreements to the escrow account by noon the next
business day. In regards to monies being wired from an investor’s bank account, the Members shall request the investors
send their wires by the next business day, however, we cannot insure the investors will forward their respective monies as per
the Rule. In regards to monies being sent from an investor’s account held at the participating broker, the funds will be
“promptly transmitted” to the escrow agent following the receipt of a completed subscription document and completed
wire instructions by the investor to send funds to the escrow account. Absent unusual circumstances, funds in customer accounts
will be transmitted by noon of the next business day. In the event that funds are sent in and the offering does not close for
any reason prior to the Termination Date set forth in the final Registration Statement, all funds will be returned to investors
promptly in accordance with the escrow agreement terms and applicable law.

 

		2.	Procedure.

 

		a.	Prior to the Closing Date (as defined below), the Investor
will:

 

		i.	Complete and execute this Subscription Agreement and deliver
it to the Underwriter at the address set forth below for forwarding to the Company:

 

Network 1 Financial Securities, Inc.

The Galleria, Building 2

2 Bridge Avenue

Red Bank, NJ 07701

Attn: Damon D. Testaverde, CEO

T: (732) 758-9001

F.: (732) 758-6671

 

		ii.	Deliver funds in an amount equal to the Purchase Price
multiplied by the number of Shares to which such Investor has subscribed to the Escrow Agent via checks made payable to the order
of “Continental Stock Transfer & Trust Company, Escrow Agent for Jerash Holdings (US), Inc.” or
wire transfer to:

 

[*]

[*]

[*]

ABA No.: [*]

Account No.: [*]

 

		3.	Closing Date; Termination Date. If the Escrow
Agent shall have received at least an aggregate amount of $5,005,000 (the “Requisite Funds”) on or before 5:00
p.m., New York City time, on May 31, 2018 (the “Termination Date”), the Escrow Agent will release
the balance of the Escrow Account for collection by the Company and the Underwriter as provided in the Escrow Agreement and the
Company shall deliver the Common Stock being purchased on the Closing Date to the Investors, through the facilities of DTC, and
such Common Stock shall be registered in such name or names and shall be in such denominations, as the Underwriter may request
by written notice to the Company (the “Closing”). The cost of original issue tax stamps and other transfer
taxes, if any, in connection with the issuance and delivery of the Common Stock by the Company to the respective Investors shall
be borne by the Company. The date on which the Escrow Agent releases the balance of the Escrow Account for collection by the Company
and the Underwriter against delivery of the Common Stock to the Investors as described above, is hereinafter referred to as the
“Closing Date.”

 

		4.	Return of Funds. If the Requisite Funds have not been received by the Escrow Agent
                                                                                                           or the Company’s listing application with The Nasdaq Capital Market does not get approved on or before the Termination
                                                                                                           Date, the Offering will be deemed terminated, the Escrow Agent will promptly return the funds to the Investors without
                                                                                                           interest or deduction and the Underwriter shall not be entitled to any compensation hereunder.

 

    	 	2	 

     

    

 

		5.	Investor Representations.

 

		a.	The Investor represents that it has received (or otherwise
had made available to it by the filing by the Company of an electronic version thereof with the Commission) the Prospectus prior
to or in connection with the receipt of this Agreement.

 

		b.	The Investor represents that it understands and hereby
acknowledges that the Investor’s subscription for the Shares indicated on the Signature Page hereto may be accepted or rejected
in whole or in part by the Company, for any reason and in their sole and absolute discretion.

 

		c.	The Investor represents that, except as set forth below,
(i) it has had no position, office or other material relationship within the past three years with the Company or persons known
to it to be affiliates of the Company, (ii) it is not a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”)
or an Associated Person (as such term is defined under the FINRA’s NASD Membership and Registration Rules Section 1011)
as of the Closing, and (iii) neither the Investor nor any group of Investors (as such term is used in Rule 13d-5 under the Exchange
Act (as defined below)) of which the Investor is a part in connection with the Offering, acquired, or obtained the right to acquire,
10% or more of the Common Stock (or securities convertible into or exercisable for Common Stock) or the voting power of the Company
on a post-transaction basis.

 

	Exceptions:	 	 
	(if no exceptions, write “none.”  If left blank, response will be deemed to be “none.”)

 

		d.	The Investor has all requisite authority (and in the case
of an individual, the capacity) to purchase the Shares, enter into this Subscription Agreement and to perform all the obligations
required to be performed by the Investor hereunder, and such purchase will not contravene any law, rule or regulation binding
on the undersigned or any investment guideline or restriction applicable to the undersigned.

 

		6.	Acceptance. No offer by the Investor to buy
Shares will be accepted and no part of the Purchase Price will be delivered to the Company until the Company has accepted such
offer, or a portion thereof, by countersigning a copy of this Agreement and delivering a fully-executed version of this Agreement,
and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time prior to such execution
and delivery by the Company. If the Company rejects a subscription, or a portion thereof, for the Shares, the deposited Purchase
Price for the rejected subscription, or a portion thereof as the case may be, shall be returned by the Escrow Agent to the Investor,
without interest thereon or deduction therefrom.

 

		7.	Company Confirmation. The Investor acknowledges
and agrees that such Investor’s receipt of the Company’s signed counterpart to this Agreement, together with the Prospectus
(or the filing by the Company of an electronic version thereof with the Commission), shall constitute written confirmation of
the Company’s sale of the Shares to such Investor.

 

		8.	Not a Firm Commitment Offering. The Investor
acknowledges that the Offering is being conducted on a “best efforts” basis and is not being underwritten on a “firm
commitment” basis by the Underwriter.

 

		9.	Termination. In the event that the Underwriter
Agreement is terminated by the Underwriter pursuant to the terms thereof, this Agreement shall terminate without any further action
on the part of the parties hereto.

 

		10.	Notices. All communications hereunder, except
as herein otherwise specifically provided, shall be in writing and shall be mailed (registered or certified mail, return receipt
requested), personally delivered or sent by facsimile transmission and confirmed, or by electronic transmission via PDF, and shall
be deemed given when so delivered or faxed and confirmed or transmitted or if mailed, two days after such mailing.

 

    	 	3	 

     

    

 

If to the Underwriter:

 

Network 1 Financial Securities, Inc.

Galleria, Penthouse

2 Bridge Avenue, Building 2

Red Bank, NJ 07701

Attn: Damon D. Testaverde, Chief Executive Officer

Fax No.: (732) 758-6671

 

With a copy (which shall not constitute notice) to:

Magri Law, LLC

2642 NE 9th Ave.

Fort Lauderdale, FL 33334

Attn: Philip Magri

Email: pmagri@magrilaw.com

Fax No.: 646-836-9200

 

If to the Company:

 

Jerash Holdings (US), Inc.

147 W. 35th Street, Room #1603

New York, New York 10001

Attn: Chin Lin Hung

Telephone: (212) 575-9085

 

With a copy (which shall not constitute notice) to:

 

James M. Jenkins, Esq.

Alexander R. McClean, Esq.

Harter Secrest & Emery LLP

1600 Bausch & Lomb Place

Rochester, New York 14604

Telephone: (585) 232-6500

 

		11.	Changes. This Agreement may not be modified
or amended except pursuant to an instrument in writing signed by the Company and the Investor.

 

		12.	Headings. The headings of the various sections
of this Agreement have been inserted for convenience of reference only and will not be deemed to be part of this Agreement.

 

		13.	Severability. In case any provision contained
in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the
remaining provisions contained herein will not in any way be affected or impaired thereby.

 

		14.	Governing Law. This Agreement will be governed
by, and construed in accordance with, the internal laws of the State of New York, without giving effect to the principles of conflicts
of law that would require the application of the laws of any other jurisdiction.

 

		15.	Counterparts. This Agreement may be executed
in two or more counterparts, each of which will constitute an original, but all of which, when taken together, will constitute
but one instrument, and will become effective when one or more counterparts have been signed by each party hereto and delivered
to the other parties.

 

[SIGNAURE PAGE FOLLOWS]

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF, the Investor has executed this Subscription
Agreement as of the date written below.

 

	Issuer:	 	JERASH HOLDINGS (US), INC.
	 	 	 
	Purchase Price per Share:	 	$7 
	 	 	 
	Number of Shares being Purchased by Investor:	 	__________________
	 	 	 
	Total Purchase Price (Number of Shares multiplied by Purchase Price:	 	$__________________

 

	INVESTOR:	 	CO-INVESTOR:
	 	 	 
	 	 	 
	Name of Investor	 	Name of Co-Investor, if applicable
	 	 	 
	 	 	 
	Signature of Investor	 	Signature of Co-Investor, if applicable
	 	 	 
	 	 	 
	Social Security Number (SSN) or Fed Tax ID (EIN)	 	Social Security Number (SSN) or Fed Tax ID (EIN)
	 	 	 
	Date:	 	 	Date:	 

 

The Shares subscribed for hereby are being
purchased as follows:

 

(Check One)

 ̈          individually

 ̈          joint
tenants

 ̈          joint
tenants with right of survivorship

 ̈          tenants
in common

 ̈          partnership

 ̈          limited
liability company

 ̈          as
custodian, trustee or agent for 

_____________________ corporation

 

    	 	5	 

     

    

 

	Investor’s Name and	 	Co-Investor’s Name 
	Address (please print)    	 	Address (please print):
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Email address:	 	Email address:
	 	 	 

 

DELIVERY INSTRUCTIONS:

 

	Please deliver my shares to my Network 1 Account number:	 	 

  

OR

 

Please Deliver shares to: 

 

 

  

	DTC Participant Number:	 
	 	 
	Name of Account at DTC Participant being credited 

with the Shares:	 
	 	 
	Account Number at DTC Participant being credited 

with the Shares:	 

 

 

 

The foregoing Subscription is hereby accepted.

 

	 	JERASH HOLDINGS (US), INC. 
	 	 	 
	 	By: 	 
	 	 	Name:  Chin Lin Hung
	 	 	Title:  President
	 	 	 
	 	Date: 	 

 

    	 	6Exhibit 10.15

 

Form of Underwriter’s Warrant Agreement

 

THE REGISTERED HOLDER OF THIS PURCHASE WARRANT,
BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT EXCEPT AS
HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE
THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE CLOSING DATE OF THE OFFERING (DEFINED BELOW) TO ANYONE
OTHER THAN (I) NETWORK 1 FINANCIAL SECURITIES, INC. OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR
(II) A BONA FIDE OFFICER OR PARTNER OF NETWORK 1 FINANCIAL SECURITIES, INC. OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.

 

THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR
TO [*] [DATE THAT IS SIX MONTHS FROM THE CLOSING DATE OF THE OFFERING]. VOID AFTER 5:00 P.M., EASTERN TIME, [*]
[DATE THAT IS FIFTH ANNIVERSARY OF EFFECTIVE DATE] 

 

COMMON STOCK PURCHASE WARRANT

For the Purchase of [*]Shares of Common
Stock

of

JERASH HOLDINGS (US), INC.

 

1.   Purchase
Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [*] (“Holder”),
as registered owner of this Purchase Warrant, to Jerash Holdings (US), Inc., a Delaware corporation (the “Company”),
Holder is entitled, at any time or from time to time from [*] [DATE THAT IS 180 DAYS FROM THE CLOSING DATE OF THE OFFERING]
(the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [DATE THAT IS FIFTH ANNIVERARY OF EFFECTIVE
DATE] (the “Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or
in part, up to [*]shares (the “Warrant Shares”) of common stock of the Company, par value $0.001 per
share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day
on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding
day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company
agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $10.50
per Warrant Share (150% of the price of the shares of common stock sold in the proposed initial public offering of Shares
(the “Offering”); provided, however, that upon the occurrence of any of the events specified in Section
6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Warrant Share and the number of Warrant
Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price”
shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term “Effective Date”
means [*], 2018, the date that the Company’s Registration Statement on Form S-1 (File No: 333-222596) was
declared effective under the Securities Act of 1933, as amended (the “Securities Act”), by the U.S. Securities
and Exchange Commission (the “Commission”).

 

     

     

    

 

2.     Exercise.

 

2.1.          Exercise
Form. In order to exercise this Purchase Warrant, the exercise form attached hereto must be duly executed and completed and
delivered to the Company, together with this Purchase Warrant and payment of the Exercise Price for the Warrant Shares being purchased
payable in cash by wire transfer of immediately available funds to an account designated by the Company or by certified check or
official bank check. If the subscription rights represented hereby shall not be exercised at or before 5:00 p.m., Eastern time,
on the Expiration Date, this Purchase Warrant shall become and be void without further force or effect, and all rights represented
hereby shall cease and expire.

 

2.2.          Cashless
Exercise. If at the time of exercise there is no effective registration statement, or the prospectus therein is not available
for the issuance, registering for resale the Warrant Shares, then in lieu of exercising this Purchase Warrant by payment of cash
or check payable to the order of the Company pursuant to Section 2.1 above, Holder may elect to receive the number of Warrant Shares
equal to the value of this Purchase Warrant (or the portion thereof being exercised), by surrender of this Purchase Warrant to
the Company, together with the exercise form attached hereto, in which event the issue to Holder, Warrant Shares in accordance
with the following formula:

 

X = Y(A-B)/A

Where,

 

X = The number of Warrant Shares to be issued to Holder;

Y = The number of Warrant Shares for which the Purchase
Warrant is being exercised;

A = The fair market value of one Share; and

B = The Exercise Price.

 

For purposes of this Section 2.2, the fair market value of a Share
is defined as follows:

 

2.2.1.     if
the Company’s Common Stock is traded on a securities exchange, the value shall be deemed to be the average of the closing
prices of the Shares on such exchange for the five (5) trading day period prior to the date the exercise form is submitted in connection
with the exercise of the Purchase Warrant;

 

2.2.2.     if
the Company’s Common Stock is actively traded over-the-counter, the value shall be deemed to be the average of the closing
bid prices of the Shares for the five (5) trading day period prior to the date the exercise form is submitted in connection with
the exercise of the Purchase Warrant; or

 

2.2.3.     if
there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Company’s
Board of Directors.

 

     

     

    

 

2.3.          Legend.
Unless the Warrant Shares are registered under the Securities Act pursuant to an effective registration statement or issued pursuant
to an exemption from the registration requirements of the Securities Act, each certificate for the securities purchased under this
Purchase Warrant shall bear a legend as follows unless such securities have been registered under the Securities Act:

 

“The securities represented
by this certificate have not been registered under the Securities Act of 1933, as amended (the “Act”), or applicable
state law. Neither the securities nor any interest therein may be offered for sale, sold or otherwise transferred except pursuant
to an effective registration statement under the Securities Act, or pursuant to an exemption from registration under the Securities
Act and applicable state law which, in the opinion of counsel to the Company, is available.”

 

 3.    Transfer.

 

3.1.          General
Restrictions. The registered Holder of this Purchase Warrant agrees by his, her or its acceptance hereof, that such Holder
will not: (a) sell, transfer, assign, pledge or hypothecate this Purchase Warrant for a period of one hundred eighty (180) days
following the Effective Date to anyone other than: (i) to an underwriter or a selected dealer participating in the Offering, or
(ii) a bona fide officer or partner of Network 1 Financial Securities, Inc. (“Network 1”) or of any such underwriter
or selected dealer, in each case in accordance with FINRA Conduct Rule 5110(g)(1), or (b) cause this Purchase Warrant or the securities
issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective
economic disposition of this Purchase Warrant or the securities hereunder, except as provided for in FINRA Rule 5110(g)(2). On
and after 180 days after the Effective Date, transfers to others may be made subject to compliance with or exemptions from applicable
securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the assignment form attached
hereto duly executed and completed, together with the Purchase Warrant and payment of all transfer taxes, if any, payable in connection
therewith. The Company shall within five (5) Business Days transfer this Purchase Warrant on the books of the Company and shall
execute and deliver a new Purchase Warrant or Purchase Warrants of like tenor to the appropriate assignee(s) expressly evidencing
the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated
by any such assignment.

 

3.2.          Restrictions
Imposed by the Securities Act. The Warrant Shares shall not be transferred unless and until: (i) the Company has received the
opinion of counsel for the Holder that the securities may be transferred pursuant to an exemption from registration under the Securities
Act and applicable state securities laws, the availability of which is established to the reasonable satisfaction of the Company
(the Company hereby agreeing that the opinion of Magri Law, LLC shall be deemed satisfactory evidence of the availability of an
exemption), or (ii) a registration statement or a post-effective amendment to the Registration Statement relating to the offer
and sale of such securities has been filed by the Company and declared effective by the Commission and compliance with applicable
state securities law has been established.

 

     

     

    

 

 

 4.    Registration Rights; Indemnification.

 

 4.1.          “Piggy-Back” Registration.

 

4.1.1.          Grant
of Right. The Holder shall have the right, for a period of no more than five (5) years from the Closing Date of the Offering
in accordance with FINRA Rule 5110(f)(2)(G)(v), to include all or any portion of the Shares underlying the Purchase Warrants (collectively,
the “Registrable Securities”) as part of any other registration of securities filed by the Company (other than
in connection with a transaction contemplated by Rule 145(a) promulgated under the Securities Act or pursuant to Form S-8 or any
equivalent form); provided, however, that if, solely in connection with any primary underwritten public offering for the
account of the Company, the managing underwriter(s) thereof shall, in its reasonable discretion, impose a limitation on the number
of shares of Common Stock which may be included in the Registration Statement because, in such underwriter(s)’ judgment,
marketing or other factors dictate such limitation is necessary to facilitate public distribution, then the Company shall be obligated
to include in such Registration Statement only such limited portion of the Registrable Securities with respect to which the Holder
requested inclusion hereunder as the underwriter shall reasonably permit. Any exclusion of Registrable Securities shall be made
pro rata among the Holders seeking to include Registrable Securities in proportion to the number of Registrable Securities sought
to be included by such Holders; provided, however, that the Company shall not exclude any Registrable Securities unless the Company
has first excluded all outstanding securities, the holders of which are not entitled to inclusion of such securities in such Registration
Statement or are not entitled to pro rata inclusion with the Registrable Securities.

 

4.1.2.          Terms.
The Company shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 4.1.1 hereof,
but the Holders shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holders to
represent them in connection with the sale of the Registrable Securities. In the event of such a proposed registration, the Company
shall furnish the then Holders of outstanding Registrable Securities with not less than thirty (30) days written notice prior to
the proposed date of filing of such registration statement. Such notice to the Holders shall continue to be given for each registration
statement filed by the Company until such time as all of the Registrable Securities have been sold by the Holder. The holders of
the Registrable Securities shall exercise the “piggy-back” rights provided for herein by giving written notice within
ten (10) days of the receipt of the Company’s notice of its intention to file a registration statement. Except as otherwise
provided in this Purchase Warrant, there shall be no limit on the number of times the Holder may request registration under this
Section 4.1.2; provided, however, that such registration rights shall terminate on the fifth anniversary of the Commencement
Date.

 

     

     

    

 

 4.2.      General Terms.

 

4.2.1.          Indemnification.
The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration statement hereunder
and each person, if any, who controls such Holders within the meaning of Section 15 of the Securities Act or Section 20 (a) of
the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense
or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing
or defending against any claim whatsoever) to which any of them may become subject under the Securities Act, the Exchange Act
or otherwise, arising from such registration statement but only to the same extent and with the same effect as the provisions
pursuant to which the Company has agreed to indemnify the Underwriter contained in Section 5.1 of the Underwriting Agreement between
the Underwriter and the Company, dated as of [*][*], 2018. The Holder(s) of the Registrable Securities to be sold pursuant to
such registration statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, against
all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred
in investigating, preparing or defending against any claim whatsoever) to which they may become subject under the Securities Act,
the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors or assigns,
in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the provisions
contained in Section 5.2 of the Underwriting Agreement pursuant to which the Underwriter have agreed to indemnify the Company.

 

4.2.2.          Exercise
of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise
their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.

 

4.2.3.          Documents
to be Delivered by Holder(s). Each of the Holder(s) participating in any of the foregoing offerings shall furnish to the Company
a completed and executed questionnaire provided by the Company requesting information customarily sought of selling security holders.

 

4.2.4.          Damages.
Should the Company fail to comply with such the provisions of Section 4.1, the Holder(s) shall, in addition to any other legal
or other relief available to the Holder(s), be entitled to seek specific performance or other equitable (including injunctive)
relief against the threatened breach of such provisions or the continuation of any such breach, without the necessity of proving
actual damages and without the necessity of posting bond or other security.

 

 5.     New Purchase Warrants to be Issued.

 

5.1.          Partial
Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Purchase Warrant may be exercised or assigned in
whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of this Purchase Warrant for cancellation,
together with the duly executed exercise or assignment form and funds sufficient to pay any Exercise Price and/or transfer tax
if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered to the Holder without charge a new Purchase
Warrant of like tenor to this Purchase Warrant in the name of the Holder evidencing the right of the Holder to purchase the number
of Shares purchasable hereunder as to which this Purchase Warrant has not been exercised or assigned.

 

5.2.          Lost
Warrant. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Purchase
Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall execute and deliver a new Purchase
Warrant of like tenor and date. Any such new Purchase Warrant executed and delivered as a result of such loss, theft, mutilation
or destruction shall constitute a substitute contractual obligation on the part of the Company.

 

     

     

    

 

 6.    Adjustments.

 

6.1.          Adjustments
to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Purchase Warrant shall
be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1.          Share
Dividends; Split Ups. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding
Shares is increased by a stock dividend payable in Shares or by a split up of Shares or other similar event, then, on the effective
day thereof, the number of Shares purchasable hereunder shall be increased in proportion to such increase in outstanding Shares,
and the Exercise Price shall be proportionately decreased.

 

6.1.2.          Aggregation
of Shares. If, after the date hereof, and subject to the provisions of Section 6.3 below, the number of outstanding Shares
is decreased by a consolidation, combination or reclassification of Shares or other similar event, then, on the effective date
thereof, the number of Shares purchasable hereunder shall be decreased in proportion to such decrease in outstanding Shares, and
the Exercise Price shall be proportionately increased.

 

6.1.3.          Replacement
of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Shares other than
a change covered by Section 6.1.1 or 6.1.2 hereof or a change that solely affects the par value of such Shares, or in the case
of any share reconstruction or amalgamation or consolidation of the Company with or into another corporation (other than a consolidation
or share reconstruction or amalgamation in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding Shares), the Holder of this Purchase Warrant shall have the right thereafter (until the expiration
of the right of exercise of this Purchase Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable
hereunder immediately prior to such event, the kind and amount of shares of stock or other securities or property (including cash)
receivable upon such reclassification, reorganization, share reconstruction or amalgamation, or consolidation, by a Holder of the
number of Shares of the Company obtainable upon exercise of this Purchase Warrant immediately prior to such event; and if any reclassification
also results in a change in Shares covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1,
6.1.2 and this Section 6.1.3. The provisions of this Section 6.1.3 shall similarly apply to successive such reclassifications,
reorganizations, share reconstructions or amalgamations, or consolidations, sales or other transfers.

 

6.1.4.          Changes
in Form of Purchase Warrant. This form of Purchase Warrant need not be changed because of any change pursuant to this Section
6.1, and Purchase Warrants issued after such change may state the same Exercise Price and the same number of Warrant Shares as
are stated in the Purchase Warrants initially issued pursuant to this Agreement. The acceptance by any Holder of the issuance of
new Purchase Warrants reflecting a required or permissive change shall not be deemed to waive any rights to an adjustment occurring
after the Commencement Date or the computation thereof.

 

     

     

    

 

6.2.          Substitute
Purchase Warrant. In case of any consolidation of the Company with, or share reconstruction or amalgamation of the Company
with or into, another corporation (other than a consolidation or share reconstruction or amalgamation which does not result in
any reclassification or change of the outstanding Shares), the corporation formed by such consolidation or share reconstruction
or amalgamation shall execute and deliver to the Holder a supplemental Purchase Warrant providing that the holder of each Purchase
Warrant then outstanding or to be outstanding shall have the right thereafter (until the stated expiration of such Purchase Warrant)
to receive, upon exercise of such Purchase Warrant, the kind and amount of shares of stock and other securities and property receivable
upon such consolidation or share reconstruction or amalgamation, by a holder of the number of Shares of the Company for which such
Purchase Warrant might have been exercised immediately prior to such consolidation, share reconstruction or amalgamation, sale
or transfer. Such supplemental Purchase Warrant shall provide for adjustments which shall be identical to the adjustments provided
for in this Section 6. The above provision of this Section shall similarly apply to successive consolidations or share reconstructions
or amalgamations.

 

6.3.          Elimination
of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Shares upon the
exercise of the Purchase Warrant, nor shall it be required to issue scrip or pay cash in lieu of any fractional interests, it being
the intent of the parties that all fractional interests shall be eliminated by rounding any fraction up or down, as the case may
be, to the nearest whole number of Shares or other securities, properties or rights.

 

7.    Reservation
and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely for the purpose
of issuance upon exercise of the Purchase Warrants, such number of Shares or other securities, properties or rights as shall be
issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of the Purchase Warrants and payment
of the Exercise Price therefor, in accordance with the terms hereof, all Shares and other securities issuable upon such exercise
shall be duly and validly issued, fully paid and non-assessable and not subject to preemptive rights of any shareholder. As long
as the Purchase Warrants shall be outstanding, the Company shall use its commercially reasonable efforts to cause all Shares issuable
upon exercise of the Purchase Warrants to be listed (subject to official notice of issuance) on the Nasdaq Capital Market or any
other market on which the Shares issued to the public in the Offering may then be listed and/or quoted.

 

 8.    Certain Notice Requirements.

 

8.1.          Holder’s
Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote or consent or to
receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder
of the Company. If, however, at any time prior to the expiration of the Purchase Warrants and their exercise, any of the events
described in Section 8.2 shall occur, then, in one or more of said events, the Company shall give written notice of such event
at least fifteen days prior to the date fixed as a record date or the date of closing the transfer books for the determination
of the shareholders entitled to such dividend, distribution, conversion or exchange of securities or subscription rights, or entitled
to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of
the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company shall deliver to each Holder
a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is
given to the shareholders.

 

     

     

    

 

8.2.          Events
Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the following
events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them to receive a dividend
or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of retained earnings,
as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer
to all the holders of its Shares any additional shares of capital stock of the Company or securities convertible into or exchangeable
for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or share reconstruction or amalgamation) or a sale
of all or substantially all of its property, assets and business shall be proposed.

 

8.3.          Notice
of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant to
Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice shall
describe the event causing the change and the method of calculating same and shall be certified as being true and accurate by the
Company’s Chief Financial Officer.

 

8.4.          Transmittal
of Notices. All notices, requests, consents and other communications under this Purchase Warrant shall be in writing and shall
be deemed to have been duly made when hand delivered, or mailed by express mail or private courier service: (i) if to the registered
Holder of the Purchase Warrant, to the address of such Holder as shown on the books of the Company, or (ii) if to the Company,
to following address or to such other address as the Company may designate by notice to the Holders:

 

	 	If to the Holder:
	 	 
	 	Network 1 Financial Securities, Inc.
	 	Galleria, Penthouse
	 	2 Bridge Avenue, Building 2
	 	Red Bank, NJ 07701
	 	Attn: Damon D. Testaverde, Director of Investment Banking
	 	Fax: (732) 758-6671

 

     

     

    

	 	With a copy (which shall not constitute notice) to:
	 	 
	 	Magri Law, LLC
	 	2642 NE 9th Ave.
	 	Fort Lauderdale, FL 33334
	 	Attn: Philip Magri
	 	Email: pmagri@magrilaw.com
	 	Telephone: (646) 303-5900
	 	Fax: (646) 836-9200
	 	 

	 	If to the Company:
	 	 
	 	Jerash Holdings (US), Inc.
	 	147 W. 35th Street, Room #1603
	 	New York, New York 10001
	 	Attn: Chin Lin Hung
	 	Telephone: (212) 575-9085

 

	 	With a copy (which shall not constitute notice) to:
	 	 
	 	James M. Jenkins, Esq.
	 	Alexander R. McClean, Esq.
	 	Harter Secrest & Emery LLP
	 	1600 Bausch & Lomb Place
	 	Rochester, New York 14604
	 	Telephone: (585) 232-6500

 

 9.    Miscellaneous.

 

9.1.          Amendments.
The Company and Network 1 may from time to time supplement or amend this Purchase Warrant without the approval of any of the Holders
in order to cure any ambiguity, to correct or supplement any provision contained herein that may be defective or inconsistent with
any other provisions herein, or to make any other provisions in regard to matters or questions arising hereunder that the Company
and Network 1 may deem necessary or desirable and that the Company and Network 1 deem shall not adversely affect the interest of
the Holders. All other modifications or amendments shall require the written consent of and be signed by the party against whom
enforcement of the modification or amendment is sought.

 

9.2.          Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of this Purchase Warrant.

 

9.3.          Entire
Agreement. This Purchase Warrant (together with the other agreements and documents being delivered pursuant to or in connection
with this Purchase Warrant) constitutes the entire agreement of the parties hereto with respect to the subject matter hereof, and
supersedes all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.

 

9.4.          Binding
Effect. This Purchase Warrant shall inure solely to the benefit of and shall be binding upon, the Holder and the Company and
their permitted assignees, respective successors, legal representative and assigns, and no other person shall have or be construed
to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Purchase Warrant or any provisions
herein contained.

 

     

     

    

9.5.          Governing
Law; Submission to Jurisdiction; Trial by Jury. This Purchase Warrant shall be governed by and construed and enforced in accordance
with the laws of the State of New York, without giving effect to conflict of laws principles thereof. The Company hereby agrees
that any action, proceeding or claim against it arising out of, or relating in any way to this Purchase Warrant shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served
upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage
prepaid, addressed to it at the address set forth in Section 8 hereof. Such mailing shall be deemed personal service and shall
be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees
and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor. The Company (on
its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the Holder hereby
irrevocably waive, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding
arising out of or relating to this Agreement or the transactions contemplated hereby.

 

9.6.          Waiver,
etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Purchase Warrant shall not
be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Purchase Warrant or
any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision of this Purchase
Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of this Purchase Warrant shall be
effective unless set forth in a written instrument executed by the party or parties against whom or which enforcement of such waiver
is sought; and no waiver of any such breach, non-compliance or non-fulfillment shall be construed or deemed to be a waiver of any
other or subsequent breach, non-compliance or non-fulfillment.

 

9.7.          Execution
in Counterparts. This Purchase Warrant may be executed in two or more counterparts, and by the different parties hereto in
separate counterparts, each of which shall be deemed to be an original, but all of which taken together shall constitute one and
the same agreement, and shall become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto. Such counterparts may be delivered by facsimile transmission or other electronic
transmission.

 

9.8.          Exchange
Agreement. As a condition of the Holder’s receipt and acceptance of this Purchase Warrant, Holder agrees that, at any
time prior to the complete exercise of this Purchase Warrant by Holder, if the Company and Network 1 enter into an agreement (“Exchange
Agreement”) pursuant to which they agree that all outstanding Purchase Warrants will be exchanged for securities or cash
or a combination of both, then Holder shall agree to such exchange and become a party to the Exchange Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

     

     

    

 

IN WITNESS WHEREOF, the Company has caused this Purchase
Warrant to be signed by its duly authorized officer as of the ____ day of _______, 2018.

  

	 	JERASH HOLDINGS (US), INC.

 

	 	By:	 
	 	Name: Choi Lin Hung
	 	Title: President

 

     

     

    

 

[Form to be used to exercise Purchase Warrant]

 

Date: __________, 20___

 

The undersigned hereby elects irrevocably to exercise the Purchase
Warrant for ______ shares of common stock, par value $0.001 per share (the “Shares”), of Jerash Holdings (US),
Inc., a Delaware corporation (the “Company”), and hereby makes payment of $____ (at the rate of $10.50 per Share)
in payment of the Exercise Price pursuant thereto. Please issue the Shares as to which this Purchase Warrant is exercised in accordance
with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for which this Purchase
Warrant has not been exercised.

 

or

 

The undersigned hereby elects irrevocably to convert its right to
purchase ___ Shares of the Company under the Purchase Warrant for ______ Shares, as determined in accordance with the following
formula:

 

X = Y(A-B)/A

Where,

 

X = The number of Shares to be issued to Holder;

Y = The number of Shares for which the Purchase Warrant
is being exercised;

A = The fair market value of one Share which is equal to
$_____; and

B = The Exercise Price which is equal to $______ per share

 

The undersigned agrees and acknowledges that the calculation set
forth above is subject to confirmation by the Company and any disagreement with respect to the calculation shall be resolved by
the Company in its sole discretion.

 

Please issue the Shares as to which this Purchase Warrant is exercised
in accordance with the instructions given below and, if applicable, a new Purchase Warrant representing the number of Shares for
which this Purchase Warrant has not been converted.

 

	Signature	 	 

 

	Signature Guaranteed	 	 

 

     

     

    

  

INSTRUCTIONS FOR REGISTRATION OF SECURITIES:

	 	 	 
	Name:	 	 
	 	(Print in Block Letters)	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

NOTICE: The signature to this form must correspond with the name
as written upon the face of the Purchase Warrant without alteration or enlargement or any change whatsoever, and must be guaranteed
by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered national securities
exchange.

 

     

     

    

 

[Form to be used to assign Purchase Warrant]

 

ASSIGNMENT

(To be executed by the registered Holder to
effect a transfer of the within Purchase Warrant):

 

FOR VALUE RECEIVED, __________________ does hereby sell,
assign and transfer unto the right to purchase shares of common stock, par value $0.001 per share, of Jerash Holdings (US), Inc.,
a Delaware corporation (the “Company”), evidenced by the Purchase Warrant and does hereby authorize the Company
to transfer such right on the books of the Company.

 

Dated: __________, 20__

 

	Signature	 	 

 

	Signature Guaranteed	 	 

 

NOTICE: The signature to this form must correspond with
the name as written upon the face of the within Purchase Warrant without alteration or enlargement or any change whatsoever, and
must be guaranteed by a bank, other than a savings bank, or by a trust company or by a firm having membership on a registered
national securities exchange.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00280-of-00352.parquet"}]]